Shares of Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven research firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $20.80.
A number of research analysts recently issued reports on the company. BTIG Research lifted their price target on Shoulder Innovations from $23.00 to $24.00 and gave the company a "buy" rating in a report on Wednesday, March 11th. The Goldman Sachs Group restated a "buy" rating on shares of Shoulder Innovations in a research report on Friday, January 9th.
Check Out Our Latest Stock Report on SI
Insider Activity at Shoulder Innovations
In related news, CEO Robert Joseph Ball purchased 2,200 shares of the firm's stock in a transaction dated Friday, March 13th. The shares were acquired at an average cost of $15.18 per share, with a total value of $33,396.00. Following the completion of the purchase, the chief executive officer directly owned 278,866 shares of the company's stock, valued at $4,233,185.88. This trade represents a 0.80% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jeffrey S. Points acquired 2,000 shares of the company's stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $15.00 per share, with a total value of $30,000.00. Following the transaction, the chief financial officer directly owned 70,785 shares in the company, valued at $1,061,775. The trade was a 2.91% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought 5,200 shares of company stock worth $78,236 over the last three months. 1.71% of the stock is owned by insiders.
Hedge Funds Weigh In On Shoulder Innovations
Several large investors have recently made changes to their positions in SI. Blue Trust Inc. acquired a new stake in Shoulder Innovations in the first quarter worth about $228,000. Millennium Management LLC acquired a new position in Shoulder Innovations during the 4th quarter valued at about $1,316,000. Walleye Capital LLC boosted its stake in shares of Shoulder Innovations by 30.1% in the 4th quarter. Walleye Capital LLC now owns 93,434 shares of the company's stock valued at $1,336,000 after purchasing an additional 21,619 shares during the last quarter. State Street Corp grew its position in shares of Shoulder Innovations by 50.6% during the 4th quarter. State Street Corp now owns 58,422 shares of the company's stock worth $835,000 after buying an additional 19,641 shares during the period. Finally, Wells Fargo & Company MN grew its position in shares of Shoulder Innovations by 66.3% during the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company's stock worth $75,000 after buying an additional 2,094 shares during the period.
Shoulder Innovations Trading Up 5.7%
SI stock opened at $13.52 on Friday. The business has a fifty day moving average price of $14.06 and a 200 day moving average price of $13.94. The company has a debt-to-equity ratio of 0.11, a current ratio of 11.07 and a quick ratio of 9.55. Shoulder Innovations has a fifty-two week low of $10.92 and a fifty-two week high of $17.94. The stock has a market capitalization of $280.17 million and a price-to-earnings ratio of -0.06.
Shoulder Innovations (NYSE:SI - Get Free Report) last posted its quarterly earnings data on Tuesday, March 10th. The company reported ($0.38) EPS for the quarter, topping analysts' consensus estimates of ($0.42) by $0.04. The company had revenue of $14.42 million for the quarter, compared to analyst estimates of $12.69 million. Shoulder Innovations had a negative return on equity of 37.68% and a negative net margin of 85.29%. Analysts expect that Shoulder Innovations will post -1.71 EPS for the current fiscal year.
About Shoulder Innovations
(
Get Free Report)
Shoulder Innovations NYSE: SI is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Shoulder Innovations, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shoulder Innovations wasn't on the list.
While Shoulder Innovations currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.